Palatin Technologies EV/EBIT PTN

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2017.

Today, Oct 23, 2026: n/m; an operating loss
Last meaningful: 0.6×; Sep 2020
9-year median: 5.9×
9-year range: 0.0× to 212×
Peer median: 2.1×

Palatin Technologies has no meaningful EV/EBIT today: it made an operating loss of $8.7M over the last twelve months.

It was last meaningful in Sep 2020, at 0.6×.

On the days it had one over the last 9 years, its median was 5.9×, from 0.0× in Mar 2020 to 212× in May 2019.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2020	0.6×	0.0×	2.2×
2019	2.4×	2.1×	212×
2018	12.1×	5.5×	14.5×
2017	9.5×	9.2×	11.5×

Against its peers

Companies in Drug Manufacturers - General nearest Palatin Technologies' size, closest first, today.

Company	EV/EBIT
PTNPalatin Technologies	n/m
ATNMActinium Pharmaceuticals	1.2×
SPROSpero Therapeutics	2.1×
LFVNLifevantage	9.6×
Peer median	2.1×

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Palatin Technologies

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.